文献速递静脉血栓栓塞

梯度压力袜作为低剂量低分子肝素辅助预防外科静脉血栓栓塞的多中心随机对照试验

Graduated Compression Stockings as an Adjunct to Low Dose Low Molecular Weight Heparin in Venous Thromboembolism Prevention in Surgery: A Multicentre Randomised Controlled Trial.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-04-07

GAPS试验旨在验证单用低剂量低分子肝素(LMWH)在预防外科患者静脉血栓栓塞(VTE)方面是否非劣于梯度压力袜(GCS)联合低剂量LMWH。研究计划纳入2236例中高危择期手术患者,以90天内所有VTE为主要终点,非劣效界值3.5%,从英国7个中心招募,招募期18个月。

要点

  • 单用低剂量LMWH可能非劣于GCS联合LMWH预防外科VTE。
  • 主要终点为90天内所有VTE,非劣效界值3.5%。
  • 计划纳入2236例中高危择期手术患者,来自英国7个中心。

核心结论

  • 旨在确定单用低剂量LMWH是否非劣于GCS联合低剂量LMWH预防VTE。

研究设计与样本

  • 多中心随机对照试验(GAPS,ISRCTN 13911492),计划纳入2236例成人择期手术中高危VTE患者,来自英国7个中心,招募期18个月。

关键数值与推荐

  • 主要终点为90天内所有VTE,非劣效界值3.5%。
  • 次要结局包括生活质量、GCS和LMWH依从性、总死亡率及GCS或LMWH相关并发症(包括出血)。

临床怎么用

  • 若结果证实非劣效,可考虑单用低剂量LMWH替代联合GCS以降低成本和简化操作。

局限性

  • 试验方案摘要未报告实际结果数据,尚无法评估非劣效性是否成立。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The evidence base upon which current global venous thromboembolism (VTE) prevention recommendations have been made is not optimal. The cost of purchasing and applying graduated compression stockings (GCS) in surgical patients is considerable and has been estimated at £63.1 million per year in England alone. OBJECTIVE: The aim was to determine whether low dose low molecular weight heparin (LMWH) alone is non-inferior to a combination of GCS and low dose LMWH for the prevention of VTE. METHODS: The randomised controlled Graduated compression as an Adjunct to Pharmacoprophylaxis in Surgery (GAPS) Trial (ISRCTN 13911492) will randomise adult elective surgical patients identified as being at moderate and high risk of VTE to receive either the current "standard" combined thromboprophylactic LMWH with GCS mechanical thromboprophylaxis, or thromboprophylactic LMWH pharmacoprophylaxis alone. To show non-inferiority (3.5% non-inferiority margin) for the primary endpoint of all VTE within 90 days, 2236 patients are required. Recruitment will be from seven UK centres. Secondary outcomes include quality of life, compliance with stockings and LMWH, overall mortality, and GCS or LMWH related complications (including bleeding). Recruitment commenced in April 2016 with the seven UK centres coming "on-line" in a staggered fashion. Recruitment will be over a total of 18 months. The GAPS trial is funded by the National Institute for Health Research Health Technology Assessment in the UK (14/140/61).

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Shalhoub J, Norrie J, Baker C, et al. Graduated Compression Stockings as an Adjunct to Low Dose Low Molecular Weight Heparin in Venous Thromboembolism Prevention in Surgery: A Multicentre Randomised Controlled Trial. Eur J Vasc Endovasc Surg. 2017. PMID: 28396238. doi:10.1016/j.ejvs.2017.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。